Literature DB >> 33231818

Cascade screening and genetic diagnosis of familial hypercholesterolemia in clusters of the Southeastern region from Brazil.

Júnea Paolucci de Paiva Silvino1, Cinthia Elim Jannes2, Mauricio Teruo Tada2, Isabella Ramos Lima2, Iêda de Fátima Oliveira Silva3, Alexandre Costa Pereira2, Karina Braga Gomes4,5.   

Abstract

Familial hypercholesterolemia (FH) is an autosomal dominant genetic disease characterized by high levels of low-density lipoprotein-cholesterol (LDLc), associated to premature cardiovascular disease. The detection of the variants related to FH is important to improve the early diagnosis in probands / index-cases (ICs) and their relatives. We included ICs with FH and their relatives, living in a small region of Minas Gerais state-Brazil, which were classified according to Dutch Lipid Clinic Network Criteria (DLCNC) and submitted to sequencing of genes related to FH (LDLR, APOB, PCSK9, LDLRAP1, LIPA, STAP1, APOE, ABCG5 e ABCG8). In a total of 143 subjects (32 ICs and 111 relatives), eight variants were identified in 91 individuals. From these variants, five were in LDLR [p.(Asp224Asn), p.(Ser854Gly), p.(Cys34Arg), p.(Asp601His), deletion of exon15 in LDLR)], one in APOB [p.(Met499Val)], one in PCSK9 [p.(Arg237Trp)] and one in APOE [p.(Pro28Leu)] genes. The variants were detected in 100% of those subjects classified as definitive, 87% as probable and 69% as possible FH cases based on DLCNC. The LDLc level was higher in individuals with corneal arch and xanthomas or xanthelasmas, as well as in pathogenic or probably pathogenic variants carriers. This study showed higher frequency of LDLR gene variants compared to other genes related to LDL metabolism in individuals with FH in Minas Gerais - Brazil and the presence of FH in relatives without previous diagnosis. Our data reinforce the importance of molecular and clinical evaluation of FH relatives in order to early diagnosis the FH, as well as cardiovascular diseases prevention.

Entities:  

Keywords:  Cardiovascular disease; Familial hypercholesterolemia; Genetic variants; LDL

Mesh:

Substances:

Year:  2020        PMID: 33231818     DOI: 10.1007/s11033-020-06014-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  2 in total

1.  Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2022-08-23

2.  Screening for Familial Hypercholesterolemia in Small Towns: Experience from 11 Brazilian Towns in the Hipercolbrasil Program.

Authors:  Cinthia Elim Jannes; Júnea Paolucci Paiva Silvino; Pãmela Rodrigues de Souza Silva; Isabella Ramos Lima; Mauricio Teruo Tada; Theo Gremen Mimary Oliveira; Raul D Santos; José Eduardo Krieger; Alexandre da Costa Pereira
Journal:  Arq Bras Cardiol       Date:  2022-04       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.